In the TODAY study and in clinical practice, failure of metformin and lifestyle modification often required the initiation of insulin therapy earlier than desired as a means of rapidly improving glycemic control to delay the long-term sequelae of hyperglycemia (nephropathy, neuropathy) (3, 5). The gene discussed is INS; the disease is Nephropathy.